SYNERGISTIC COMBINATION OF TXNR INHIBITORS AND ASCORBATE FOR TREATMENT OF B CELL MALIGNANCIES

• 收藏
• 分享

专利权人:

Warszawski Uniwersytet Medyczny

发明人:

申请号：

EP15461585.0

公开号：

EP3181118B1

申请日:

2015.14.12

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

The present invention relates to a kind of prooxidant collaborative combinations to B cell malignant tumour, such as B cell lymphoma, including a thioredoxin reductase inhibiter, is selected from including Anranofin and SK053, L shapes or D-ascorbate. Combination synergy cytotoxic effect of the invention applies towards pernicious, rather than normal B cells.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/